Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-38,100
Closed -$69.3K 13668
2025
Q2
$69.3K Sell
38,100
-13,700
-26% -$29.7K ﹤0.01% 11594
2025
Q1
$114K Buy
51,800
+14,000
+37% +$51.4K ﹤0.01% 11272
2024
Q4
$156K Buy
37,800
+16,500
+77% +$49.7K ﹤0.01% 10814
2024
Q3
$36.2K Buy
21,300
+8,400
+65% +$14.2K ﹤0.01% 12256
2024
Q2
$21.4K Sell
12,900
-13,500
-51% -$49.7K ﹤0.01% 12574
2024
Q1
$289K Buy
26,400
+22,000
+500% +$132K ﹤0.01% 9526
2023
Q4
$16.1K Sell
4,400
-14,100
-76% -$35.6K ﹤0.01% 12806
2023
Q3
$57K Sell
18,500
-11,600
-39% -$53.1K ﹤0.01% 11597
2023
Q2
$144K Buy
30,100
+3,600
+14% +$19.9K ﹤0.01% 10408
2023
Q1
$115K Sell
26,500
-45,900
-63% -$292K ﹤0.01% 11067
2022
Q4
$358K Buy
+72,400
New +$900K ﹤0.01% 8940

Other funds holding NOTV

Citadel Advisors's NOTV Position: Q4 2025 in Review

Citadel Advisors sold out of Inotiv (NOTV) in Q4 2025, closing a stake of 255,858 shares — an estimated $267K sold.

Citadel Advisors first reported a position in NOTV in Q1 2014 and held it in 25 quarters. The position peaked at $1.54M in Q1 2022. 57 funds tracked by Wall St. Rank hold NOTV as of Q4 2025.

  • Citadel Advisors reported no remaining Inotiv position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 255,858 Inotiv shares in Q4 2025, an estimated $267K.
  • Citadel Advisors first reported a position in Inotiv in Q1 2014 and held it in 25 quarters.
  • Citadel Advisors's Inotiv position peaked at $1.54M in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Inotiv as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.